Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal-bolus treatment in people with Type 1 diabetes: 1-year results from a randomized clinical trial (BOOST® T1). (Q42329441)

From Wikidata
Jump to navigation Jump to search
scientific article published on 16 January 2016
edit
Language Label Description Also known as
English
Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal-bolus treatment in people with Type 1 diabetes: 1-year results from a randomized clinical trial (BOOST® T1).
scientific article published on 16 January 2016

    Statements

    Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal-bolus treatment in people with Type 1 diabetes: 1-year results from a randomized clinical trial (BOOST® T1). (English)
    1 reference
    I B Hirsch
    1 reference
    H Mersebach
    1 reference
    L Bardtrum
    1 reference
    K Hermansen
    1 reference
    16 January 2016
    1 reference
    34
    1 reference
    167-173
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit